IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 13 holdings | $55.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Amgen Inc(AMGN)CallCOM031162100$18.7M60,00033.5%
Blueprint Medicines Corp(2L9)COM09627Y109$7.4M83,92613.3%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$7.0M550,13012.6%
Protagonist Therapeutics Inc(PTGX)COM74366E102$4.0M81,6927.1%
Kymera Therapeutics Inc(KYMR)COM501575104$3.8M138,5216.8%
Precision Biosciences Inc(DTIL)COM NEW74019P207$3.5M726,1496.2%
Arvinas Inc(ARVN)COM04335A105$2.5M360,7664.5%
Regenxbio Inc(RGNX)COM75901B107$1.9M271,3023.5%
Adicet BIO Inc(TORCEUR)COM007002108$1.9M2,456,1943.3%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$1.5M171,6952.6%
Immatics N.v(IMTX)SHSN44445109$1.4M304,9022.5%
Repare Therapeutics Inc(RPTX)COM760273102$1.3M1,293,7152.3%
Zymeworks Inc(ZYME)COM98985Y108$1.0M84,4821.8%